Literature DB >> 3108060

Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?

M Greaves, C Pickering, G Knight, A J Boulton, J Ball, J D Ward, F E Preston.   

Abstract

Factor VIII-related antigen and von Willebrand factor are synthesised by and released from vascular endothelium. Acute increases in the plasma concentration of these proteins may reflect endothelial cell damage. We have thus measured the plasma concentration of factor VIII-related antigen and von Willebrand factor, together with procoagulant factor VIII, during the course of acute diabetic ketoacidosis in seven patients. In addition, evidence for qualitative changes in the factor VIII complex was sought. Plasma factor VIII-related antigen and von Willebrand factor were markedly increased (plasma factor VIII-related antigen at presentation, median 2.75 U/ml; von Willebrand factor 2.95 U/ml) and returned toward normal with clinical and biochemical resolution (plasma factor VIII-related antigen at clinical recovery, median 1.80 U/ml; von Willebrand factor 2.05 U/ml). Plasma procoagulant factor VIII followed a similar pattern, but levels were less elevated (plasma procoagulant factor VIII, at presentation, median 1.6 U/ml; at clinical recovery, 1.2 U/ml). Crossed immunoelectrophoresis and sodium dodecyl sulphate-acrylamide electrophoresis with autoradiographic identification of multimeric structure revealed no evidence of structurally abnormal factor VIII-related antigen in diabetic ketoacidosis. However, an extra peak on crossed immunoelectrophoresis ("pre-peak") was a feature in the acute phase ketoacidotic plasma in six subjects, and may represent aggregated factor VIII. Changes in plasma factor VIII are a feature of diabetic ketoacidosis and, whilst not specific to this condition, may be the result of endothelial cell damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108060     DOI: 10.1007/bf00274221

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  INCREASED ACTIVIY OF "ANTI-WILLEBRAND FACTOR" IN DIABETIC PLASMA.

Authors:  A E ODEGAARD; A J HELLEM
Journal:  Thromb Diath Haemorrh       Date:  1964-04-15

2.  Cerebral intravascular coagulation in diabetic ketoacidosis.

Authors:  W R Timperley; F E Preston; J D Ward
Journal:  Lancet       Date:  1974-05-18       Impact factor: 79.321

3.  Factor VIII antigen pre-peak.

Authors:  A Girolami; A Sticchi; G Cappellato; V Quaino
Journal:  Lancet       Date:  1980-02-02       Impact factor: 79.321

4.  Factor VIII antigen pre-peak.

Authors:  M A Howard; J Perkin; J Koutts
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

5.  Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIIIR:WF) in diabetes mellitus.

Authors:  J Gonzalez; J A Colwell; K E Sarji; R M Nair; J Sagel
Journal:  Thromb Res       Date:  1980 Jan 1-15       Impact factor: 3.944

6.  Elevated factor VIII activity and factor VIII-related antigen in diabetic children without vascular disease.

Authors:  M H Borkenstein; W E Muntean
Journal:  Diabetes       Date:  1982-11       Impact factor: 9.461

7.  Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy.

Authors:  A M Brooks; S Hussein; C N Chesterman; J F Martin; F P Alford; D G Penington
Journal:  Thromb Haemost       Date:  1983-04-28       Impact factor: 5.249

8.  Factor VIII-related antigen pre-peak on crossed immunoelectrophoresis: a non-random phenomenon.

Authors:  C H Miller; M W Hilgartner; R C LeStrange; G W McLaughlin
Journal:  Thromb Res       Date:  1982 Jan 1-15       Impact factor: 3.944

9.  Haemostatic variables associated with diabetes and its complications.

Authors:  J H Fuller; H Keen; R J Jarrett; T Omer; T W Meade; R Chakrabarti; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-10-20

10.  Elevation of Factor VIII coagulant activity over Factor VIII coagulant antigen in diabetic children without vascular disease. A sign of activation of the Factor VIII coagulant moiety during poor diabetes control.

Authors:  W E Muntean; M H Borkenstein; J Haas
Journal:  Diabetes       Date:  1985-02       Impact factor: 9.461

View more
  8 in total

Review 1.  Hypoxia and inflammatory synovitis: observations and speculation.

Authors:  C R Stevens; R B Williams; A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

2.  Assessment of endothelial function using plasma markers.

Authors:  A Blann; G Lip
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

3.  Plasma Levels of Nitrites/Nitrates in Patients with Chronic Atrial Fibrillation are Increased after Electrical Restoration of Sinus Rhythm.

Authors:  Dragana Nikitovic; Evangelos A Zacharis; Emmanuel G Manios; Nikki E Malliaraki; Emmanuel M Kanoupakis; Katerina I Sfiridaki; Emmanuel I Skalidis; Andreas N Margioris; Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2002-10       Impact factor: 1.900

4.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Br Heart J       Date:  1991-11

5.  Diabetic ketoacidosis-associated stroke in children and youth.

Authors:  Jennifer Ruth Foster; Gavin Morrison; Douglas D Fraser
Journal:  Stroke Res Treat       Date:  2011-02-22

6.  Thrombotic Thrombocytopenic Purpura in a Child with Diabetic Ketoacidosis.

Authors:  Neda Mostofizadeh; Serajaddin Arefnia; Mahin Hashemipour; Elham Hashemi Dehkordi
Journal:  Adv Biomed Res       Date:  2018-02-21

7.  Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis.

Authors:  James A Milburn; Isobel Ford; Nicola J Mutch; Nicholas Fluck; Julie Brittenden
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

8.  Thrombocytopenia-associated multiorgan failure occurring in an infant at the onset of type 1 diabetes successfully treated with fresh frozen plasma.

Authors:  Revati Kumar; Brent McSharry; Peter Bradbeer; Esko Wiltshire; Craig Jefferies
Journal:  Clin Case Rep       Date:  2016-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.